olaparib

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer Phase II Results

We know that prostate cancer is a heterogeneous disease, but most of our treatments are not based on the different molecular stratification exhibited by the disease. One of the differences we do recognize in the cancer is that some of the tumors have genetic DNA-repair defects. There has been evidence that in those cancers exhibiting [...]

By Malecare|2020-02-04T11:43:17-05:00March 31st, 2016|Advanced Prostate Cancer, Clinical Trials & Research, genetics, olaparnib, PARP inhibitors, Uncategorized|0 Comments

Can PARP Inhibitors Like Olaparib Provide Life Extension For Men With Early Disease?

The drugs called PARP inhibitors have been increasing discussed in the world of prostate cancer. There is every good reason to believe that we will continue to hear more about them and for certain select men with prostate cancer they will probably become a part of their treatment. In a recent paper published in the [...]

By Malecare|2023-07-08T15:57:45-04:00March 4th, 2016|Advanced Prostate Cancer, Clinical Trials, Clinical Trials & Research, Drugs & Treatments, olaparnib,